Nimbus Health

What Nimbus Health does

Nimbus Health GmbH is a Frankfurt-based pharmaceutical wholesaler specializing in medical cannabis distribution to licensed pharmacies across Germany. Founded following the March 2017 'Cannabis als Medizin Gesetz,' the company operates a B2B distribution model offering over 600 cannabis flower varieties, more than 200 cannabis extracts, and Dronabinol preparations to German pharmacies serving approximately 150,000 patients receiving cannabis-based therapies nationally. The company holds an exclusive German distribution partnership with New Zealand-based Rua Bioscience (a Māori-founded GMP-certified producer) and operates its own temperature-controlled logistics infrastructure guaranteeing 24-hour delivery in the 15–25°C range required for medicinal product integrity.

The company's product portfolio centers on three pillars: the validated THC/CBD-Kombitest (a DIN EN ISO/IEC 17025:2018-compliant rapid identity testing kit for ApBetrO-regulated pharmacy workflows), the BOTANICS sub-brand positioned for patient affordability, and the RUA product line sourced from the exclusive Rua Bioscience partnership. Core technology is logistics-grade: temperature-monitored transport, multi-channel ordering infrastructure (phone, email, fax, web shop), and same-day dispatch for orders placed before 4 PM. The company also provides compliance-adjacent services including prescription validation guidance, alternative product sourcing, and retax prevention support — embedding itself in pharmacy regulatory workflows rather than competing purely on price.

The business model is wholesale pharmaceutical distribution with quote-based pricing to pharmacies, a dedicated field and inside sales organization (Head of Sales, Sales Manager, Sales Expert), and operational scale of 1–10 employees. The company is governed by four managing directors (Linus Maximilian Weber, Dr. Alessandro Rossoni, Patrick Aghanian, Ozan Temizkan) and operates from a Frankfurt headquarters with a distribution warehouse in Offenbach am Main. Geographic scope is limited to the domestic German market with no evidence of cross-border expansion or institutional venture backing beyond a nominal 2018 seed event.

Name

Nimbus Health

Legal name

Nimbus Health GmbH

Website

https://nimbus.health

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Nimbus Health GmbH is a Frankfurt-based B2B pharmaceutical wholesaler distributing medical cannabis flowers, extracts, and Dronabinol preparations to licensed pharmacies across Germany, offering 600+ flower varieties, validated identity testing kits, and 24-hour temperature-controlled nationwide delivery.

Ownership category

akta.pro rank

Product category

Medical Cannabis Pharmaceutical Wholesale

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Medical Cannabis Delivery & Online Ordering (CRANAGAG)

akta.pro secondary industry

Medical Cannabis Dispensaries (CRANAFAB)

Keywords

• Medical cannabis wholesale
• Pharmaceutical distribution
• Cannabis pharmacy supply
• Pharmaceutical identity testing
• GMP-certified cannabis products

Headquarters

HQ city

Frankfurt

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Wholesale distribution of medical cannabis products (dried flowers, extracts, Dronabinol preparations) and pharmaceutical testing products (THC/CBD combination tests) to licensed pharmacies in Germany. Revenue generated through product sales at pharmacy acquisition prices.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Nimbus Health is a German pharmaceutical wholesaler that distributes medical cannabis — over 600 varieties of dried cannabis flowers, more than 200 cannabis extracts, and Dronabinol preparations — to licensed pharmacies for dispensing to patients. Operations are anchored by a pharmacy-facing webshop, phone/email/fax ordering, temperature-controlled (15–25 °C) 24-hour nationwide delivery, and a validated THC/CBD-Kombitest identity testing kit that supports ApBetrO-compliant pharmacy workflows.

Product overview

Nimbus Health GmbH is a Frankfurt-based pharmaceutical distributor specializing in medical cannabis for the German market. The company operates a B2B model serving pharmacies and medical professionals, offering over 600 varieties of dried cannabis flowers, more than 200 cannabis extracts, and dronabinol preparations. The core product portfolio includes: the THC/CBD-Kombitest (a diagnostic rapid test kit for pharmacy identity verification), the Botanics sub-brand of medical cannabis flowers emphasizing affordability and patient accessibility, and an exclusive distribution partnership with New Zealand-based Rua Bioscience. Nimbus Health provides comprehensive support services including prescription processing guidance, 24-hour delivery, and temperature-controlled logistics (15-25°C) for pharmacies.

Differentiator

Problem solved

Functional benefit

Brands

• BOTANICS: Medical cannabis flower brand offering GMP-quality products to patient specifications at patient-friendly prices, emphasizing 'Medical for Everyone' commitment
• THC/CBD-Kombitest
• RUA

Products and services

• Medical Cannabis Wholesale (Flowers, Extracts, Dronabinol)

Quantifiable outcome

• 24-hour delivery to pharmacies nationwide for orders placed before 4 PM
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Rua BiosciencecoreChannel Partner/ Reseller/ DistributorExclusive German distribution partnership. Rua Bioscience is a New Zealand medical cannabis company founded by Māori, specializing in unique cannabis genetics cultivated in Ruatorea. Nimbus Health distributes Rua Bioscience products exclusively in Germany. Rua operates GMP-certified facilities with 184m2 indoor cultivation and 4000m2 outdoor production area, capable of producing up to 160kg of cannabis flowers annually.

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Cansativa: Frankfurt-based medical cannabis wholesale distributor serving German pharmacies with a comparable B2B model, broad flower/extract catalog, and pharmacy-focused digital ordering. Cansativa is Nimbus's closest direct competitor in the German pharmacy wholesale channel.
• Cannamedical Pharma: German medical cannabis distributor supplying pharmacies with cannabis flowers, extracts, and APIs under EU-GMP standards. Operates a similar B2B pharmacy wholesale model targeting the same German customer base.
• Four 20 Pharma: German medical cannabis producer and distributor offering EU-GMP flowers and extracts to pharmacies. Comparable product portfolio and pharmacy distribution channel, with vertical integration into cultivation.
• Demecan: German medical cannabis company combining domestic cultivation with pharmacy distribution. Competes directly with Nimbus on the German pharmacy wholesale channel and adds domestic production capability as a differentiator.

Broad incumbents

• Tilray Medical: Global medical cannabis producer with a German subsidiary distributing flowers, extracts, and Dronabinol preparations to pharmacies. Larger international player with broader portfolio and stronger cultivation footprint than Nimbus.
• Aphria Rx Germany (Tilray Brands): German arm of a major international medical cannabis operator supplying pharmacies with full-spectrum medical cannabis products. Competes in the same channel with substantially greater scale and brand recognition.
• Bedrocan: Dutch medical cannabis producer with long-standing presence in Germany supplying standardized cannabis flowers to pharmacies. Competes at the product level with Nimbus on the same pharmacy shelves.
• STADA Arzneimittel (medical cannabis portfolio): Major European generics and specialty pharmaceutical company with a growing medical cannabis distribution presence in Germany. Brings much larger commercial reach and pharmacy relationships to the same category.

Emerging players

• Sanity Group: Berlin-based European medical and consumer cannabis company with German pharmacy distribution and adjacent consumer brands. Overlaps with Nimbus in medical cannabis wholesale while also pursuing adjacent consumer categories.

Regional players

• Cannaray: European medical cannabis operator with presence in Germany and other EU markets. Comparable pharmacy-channel focus but broader geographic footprint provides useful cross-market comparison.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/NimbusHealthGER
• Facebookfacebook.com/nimbushealthger
• Instagraminstagram.com/nimbushealth

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nimbus Health